BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23475795)

  • 1. Cardiac surgery for ergotamine-induced multivalvular heart disease.
    Lazopoulos G; Papaioannou G; Kantartzis M
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):435-7. PubMed ID: 23475795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature.
    Hendrikx M; Van Dorpe J; Flameng W; Daenen W
    J Heart Valve Dis; 1996 Mar; 5(2):235-7. PubMed ID: 8665020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From headache to heartache: ergotamine-induced aortic and mitral valvulopathy.
    Patel SM; Ohori NP; Badhwar V; Cavalcante JL
    J Am Coll Cardiol; 2013 Dec; 62(22):2144. PubMed ID: 24067402
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical case of the month. Triple valvular dysfunction associated with long-term ergotamine therapy].
    Goujon-Dubois J; el Allaf D
    Rev Med Liege; 2003 Feb; 58(2):70-2. PubMed ID: 12693305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
    Creutzig A
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1736. PubMed ID: 1425287
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reconstructive techniques for valvular heart disease].
    Detter C; Wipper S; Reichenspurner H
    Dtsch Med Wochenschr; 2007 Jan; 132(3):97-102. PubMed ID: 17219344
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre study.
    Maréchaux S; Jeu A; Jobic Y; Ederhy S; Donal E; Réant P; Abouth S; Arnasteen E; Boulanger J; Ennezat PV; Garban T; Szymanski C; Tribouilloy C
    Arch Cardiovasc Dis; 2013; 106(6-7):349-56. PubMed ID: 23876809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgery of combined heart valve diseases by valve replacement, with special reference to the surgical plans in relation to organic or functional changes of the heart valve].
    Asano K
    Nihon Kyobu Geka Gakkai Zasshi; 1972 Mar; 20(3):242-6. PubMed ID: 4676513
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognosis of patients with carcinoid heart disease after valvular surgery.
    Manoly I; McAnelly SL; Sriskandarajah S; McLaughlin KE
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):302-5. PubMed ID: 24812331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Valvular regurgitation caused by anorectic agents].
    Melero Tejedor JM; Rodríguez Bailón I; Such Martínez M; Porras Martín C; Olalla Mercadé E; Espinosa Caliani JS
    Rev Esp Cardiol; 2000 Dec; 53(12):1667-70. PubMed ID: 11171493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term results of valvuloplastic surgery for acquired valvular disease].
    Nihon Kyobu Geka Gakkai Zasshi; 1993 May; 41(5):855-66. PubMed ID: 8336022
    [No Abstract]   [Full Text] [Related]  

  • 12. Occurrence of left-sided heart valve involvement before right-sided heart valve involvement in carcinoid heart disease.
    Marupakula V; Vinales KL; Najib MQ; Lanza LA; Lee HR; Chaliki HP
    Eur J Echocardiogr; 2011 Mar; 12(3):E18. PubMed ID: 21169284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The year in valvular heart disease.
    Rahimtoola SH
    J Am Coll Cardiol; 2012 Jul; 60(2):85-95. PubMed ID: 22578924
    [No Abstract]   [Full Text] [Related]  

  • 14. Indications for surgery in patients with acquired valvular disease.
    Ellis LB
    Cardiovasc Clin; 1971; 3(2):61-9. PubMed ID: 5138245
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiac multivalvular substitutions].
    Donatelli R
    Cardiol Prat; 1967 Apr; 18(2):43-6. PubMed ID: 5609402
    [No Abstract]   [Full Text] [Related]  

  • 16. [Severe insuffiency of the aortic and tricuspidal valves associated with pergolide use].
    van Strater AC; Bax JJ; van Hilten JJ; Jukema JW
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):891-4. PubMed ID: 15868996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature.
    Hauck AJ; Edwards WD; Danielson GK; Mullany CJ; Bresnahan DR
    Arch Pathol Lab Med; 1990 Jan; 114(1):62-4. PubMed ID: 2403780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of biodegradable annuloplasty ring for pediatric valvuloplasty operations.
    Cikirikcioglu M; Walpoth BH
    J Card Surg; 2008; 23(2):182-3. PubMed ID: 18304143
    [No Abstract]   [Full Text] [Related]  

  • 19. Bromocriptine use and the risk of valvular heart disease.
    Tan LC; Ng KK; Au WL; Lee RK; Chan YH; Tan NC
    Mov Disord; 2009 Feb; 24(3):344-9. PubMed ID: 18989898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tricuspid valve surgery secondary to mitral and aortal valve replacement].
    Ostrowski S; Zasłonka J; Walczak A; Stefaniak B; Jaszewski R; Jander S; Iwaszkiewicz A
    Kardiol Pol; 2004 Feb; 60 Suppl 1():I-31-3. PubMed ID: 15247941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.